Robert J. Markelewicz's most recent trade in Abpro Holdings Inc. was a trade of 538,600 Stock option (right to buy) done . Disclosure was reported to the exchange on Nov. 13, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Abpro Holdings Inc. | Robert J. Markelewicz | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 538,600 | 538,600 | - | - | Stock option (right to buy) | |
Abpro Holdings Inc. | Robert J. Markelewicz | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 74,600 | 74,600 | - | - | Stock option (right to buy) | |
Abpro Holdings Inc. | Robert J. Markelewicz | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 41,700 | 41,700 | - | - | Stock option (right to buy) | |
Abpro Holdings Inc. | Robert J. Markelewicz | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 40,800 | 40,800 | - | - | Stock option (right to buy) | |
Abpro Holdings Inc. | Robert J. Markelewicz | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 29,800 | 29,800 | - | - | Stock option (right to buy) | |
Abpro Holdings Inc. | Robert J. Markelewicz | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 24,300 | 24,300 | - | - | Stock option (right to buy) | |
Abpro Holdings Inc. | Robert J. Markelewicz | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 10,200 | 10,200 | - | - | Stock option (right to buy) |